CN Patent
CN116898874A — 用于治疗胎儿或婴儿铁缺乏的铁碳水化合物复合物
Assigned to Pharmacosmos Holding AS · Expires 2023-10-20 · 3y expired
What this patent protects
本文公开了包含铁碳水化合物复合物的药物组合物,其用于治疗或预防胎儿或婴儿的铁缺乏的方法中,其中将所述铁碳水化合物复合物施用至所述胎儿或婴儿的母亲。
USPTO Abstract
本文公开了包含铁碳水化合物复合物的药物组合物,其用于治疗或预防胎儿或婴儿的铁缺乏的方法中,其中将所述铁碳水化合物复合物施用至所述胎儿或婴儿的母亲。
Drugs covered by this patent
- Monoferric (FERRIC DERISOMALTOSE) · Pharmacosmos
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.